Tel Aviv University researchers have developed a targeted method of delivering locked nucleic acids (LNAs) using lipid nanoparticles, achieving therapeutic effect against inflammatory bowel disease in preclinical models – without side effects. It could also be used for heart diseases, and Parkinson’s.
https://tautrust.org/gene-therapy-shows-promise-for-inflammatory-bowel-disease/